Renhe Pharmacy Co Ltd (000650) - Total Liabilities
Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) has total liabilities worth CN¥823.87 Million CNY (≈ $120.56 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 000650 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Renhe Pharmacy Co Ltd - Total Liabilities Trend (1993–2025)
This chart illustrates how Renhe Pharmacy Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Renhe Pharmacy Co Ltd.
Renhe Pharmacy Co Ltd Competitors by Total Liabilities
The table below lists competitors of Renhe Pharmacy Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
|
China | CN¥942.80 Million |
|
Shenzhen United Winners Laser Co Ltd
SHG:688518
|
China | CN¥4.62 Billion |
|
Evergreen Steel Corp
TW:2211
|
Taiwan | NT$8.16 Billion |
|
Fengfan Power
SHG:601700
|
China | CN¥4.80 Billion |
|
Inner Mongolia ERDOS Resources Co Ltd B
SHG:900936
|
China | $19.27 Billion |
|
Green Plains Renewable Energy Inc
NASDAQ:GPRE
|
USA | $795.73 Million |
|
Zhejiang Wansheng Co Ltd
SHG:603010
|
China | CN¥3.34 Billion |
|
Qingdao Port International Co. Ltd
F:0QP
|
Germany | €16.46 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down Renhe Pharmacy Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Renhe Pharmacy Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Renhe Pharmacy Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Renhe Pharmacy Co Ltd (1993–2025)
The table below shows the annual total liabilities of Renhe Pharmacy Co Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥803.26 Million ≈ $117.54 Million |
+18.74% |
| 2024-12-31 | CN¥676.48 Million ≈ $98.99 Million |
-14.39% |
| 2023-12-31 | CN¥790.18 Million ≈ $115.63 Million |
-34.69% |
| 2022-12-31 | CN¥1.21 Billion ≈ $177.04 Million |
+23.33% |
| 2021-12-31 | CN¥981.00 Million ≈ $143.55 Million |
+41.25% |
| 2020-12-31 | CN¥694.54 Million ≈ $101.63 Million |
+9.81% |
| 2019-12-31 | CN¥632.47 Million ≈ $92.55 Million |
-9.86% |
| 2018-12-31 | CN¥701.67 Million ≈ $102.68 Million |
+0.97% |
| 2017-12-31 | CN¥694.95 Million ≈ $101.69 Million |
+5.23% |
| 2016-12-31 | CN¥660.41 Million ≈ $96.64 Million |
+18.91% |
| 2015-12-31 | CN¥555.41 Million ≈ $81.27 Million |
+27.66% |
| 2014-12-31 | CN¥435.06 Million ≈ $63.66 Million |
+11.59% |
| 2013-12-31 | CN¥389.86 Million ≈ $57.05 Million |
+1.85% |
| 2012-12-31 | CN¥382.80 Million ≈ $56.02 Million |
-16.91% |
| 2011-12-31 | CN¥460.68 Million ≈ $67.41 Million |
-18.63% |
| 2010-12-31 | CN¥566.13 Million ≈ $82.84 Million |
+177.90% |
| 2009-12-31 | CN¥203.72 Million ≈ $29.81 Million |
+54.10% |
| 2008-12-31 | CN¥132.20 Million ≈ $19.35 Million |
+80.99% |
| 2007-12-31 | CN¥73.04 Million ≈ $10.69 Million |
-5.16% |
| 2006-12-31 | CN¥77.01 Million ≈ $11.27 Million |
-81.18% |
| 2005-12-31 | CN¥409.12 Million ≈ $59.87 Million |
-5.23% |
| 2004-12-31 | CN¥431.68 Million ≈ $63.17 Million |
-2.16% |
| 2003-12-31 | CN¥441.21 Million ≈ $64.56 Million |
+4.82% |
| 2002-12-31 | CN¥420.93 Million ≈ $61.59 Million |
+10.67% |
| 2001-12-31 | CN¥380.36 Million ≈ $55.66 Million |
+24.18% |
| 2000-12-31 | CN¥306.29 Million ≈ $44.82 Million |
+42.64% |
| 1999-12-31 | CN¥214.72 Million ≈ $31.42 Million |
+70.01% |
| 1998-12-31 | CN¥126.30 Million ≈ $18.48 Million |
+6.35% |
| 1997-12-31 | CN¥118.76 Million ≈ $17.38 Million |
-6.25% |
| 1996-12-31 | CN¥126.67 Million ≈ $18.54 Million |
+5.97% |
| 1995-12-31 | CN¥119.54 Million ≈ $17.49 Million |
-3.67% |
| 1994-12-31 | CN¥124.08 Million ≈ $18.16 Million |
+6.29% |
| 1993-12-31 | CN¥116.74 Million ≈ $17.08 Million |
-- |
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more